Airway mucosal thickening and bronchial hyperresponsiveness induced by inhaled β2-agonist in mice

Chest

Volumn 126, Issue 1, 2004, Pages 205-212

  Tamaoki, Jun ^a   Tagaya, Etsuko ^a   Kawatani, Kiyomi ^a   Nakata, Junko ^a   Endo, Yumie ^a   Nagai, Atsushi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Airway epithelium; Airway remodeling; Bronchial hyperresponsiveness; Corticosteroid; Salbutamol

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BROXURIDINE; BUDESONIDE; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SALBUTAMOL;

AEROSOL; AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MORPHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; SYMPTOM;

EID: 3242698916     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.1.205     Document Type: Article

References (28)

1. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164:S28-S38
2. Fish JE, Peters SP. Airway remodeling and persistent airway obstruction in asthma. J Allergy Clin Immunol 1999; 104:509-516
3. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998; 53:21-27
4. Vignola AM, Chanez P, Chiappara G, et al. Growth factors in the remodelling of asthma. Allergy Clin Immunol Int 1998; 10:149-153
5. Chetta A, Foresi A, Del Donno M, et al. Airway remodeling is a distinctive feature of asthma and is related to severity of asthma. Chest 1997; 111:852-857
6. Nishimura K, Tamaoki J, Isono K, et al. β-Adrenergic receptor-mediated growth of human airway epithelial cell lines. Eur Respir J 2002; 20:353-358
7. Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162:1308-1313
8. Gibson PG, Saltos N, Fakes K. Acute anti-flammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 2001; 163:32-36
9. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57:309-316
10. Fernandes D, Guida E, Koutsoubos V, et al. Glucocorticosteroids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 1999; 21:77-88
11. Greenburg AK, Hu J, Basu S, et al. Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Respir Cell Mol Biol 2002; 27:320-328
12. Sakagami M, Kinoshita W, Sakon K, et al. Functional contribution of lung, nasal and gastrointestinal absorption to the systemic level following nose-only aerosol exposure in rats: a case study of 3.7-μm fluorescein aerosols. Arch Toxicol 2003; 77:321-329
13. Reiners JJ Jr, Lee JY, Clift RE, et al. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol Pharmacol 1998; 53:438-445
14. Duncia JV, Santella JB III, Higley CA, et al. MEK inhibitors: the chemistry and biological activity of U0126, its analog, and cyclization products. Bioorg Med Chem Lett 1998; 8:2839-2844
15. Strohm C, Barancik T, Bruhl ML, et al. Inhibition of the ER-kinase cascade by PD98059 and U0126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 2000; 36:218-229
16. Clemons AP, Holstein DM, Galli A, et al. Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059. Pancreas 2002; 25:251-259
17. Wattenberg LW, Wiedmann TS, Estensen RD, et al. Chemoprevention of pulmonary carcinogenesis by brief exposure to aerosolized budesonide or beclomethasone propionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis 2000; 21:179-182
18. Bicknell S, van Eeden S, Hayashi S, et al. A nonradioisotopic method for tracing neutrophils in vivo using 5-bromo-2′-deoxyuridine. Am J Respir Cell Mol Biol 1994; 10:16-23
19. Hamelmann E, Schwarze J, Takeda K, et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156:766-775
20. Vathenen AS, Knox AJ, Higgins BG, et al. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988; 1:554-558
21. Wiggs BR, Bosken C, Pare PD, et al. A model of airway narrowing in asthma and chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145:1251-1258
22. Kamachi A, Munakata M, Nasuhara Y, et al. Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma. Thorax 2001; 56:19-24
23. 2,-agonists and corticosteroids. Eur Respir J 2002; 19:182-191
24. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22
25. Barnes NC, Burke CM, Poulter LW, et al. The anti-inflammatory profile of inhaled corticosteroids: biopsy studies in asthmatic patients. Respir Med 2000; 94(suppl):S16-S21
26. Shore SA, Johnson RA, Schwartzman IN, et al. Ozone-induced airway hyperresponsiveness is reduced in immature mice. J Appl Physiol 2002; 92:1019-1028
27. Cochran JR, Khan AM, Elidemir O, et al. Influence of lipopolysaccharide exposure on airway function and allergic responses in developing mice. Pediatr Pulmonol 2002; 34:267-277
28. Knox AJ, Pang L. Glucocorticoid and beta-adrenoceptor agonist interactions in asthma. Lancet 2002; 360:1265-1266